期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

鲍曼不动杆菌对碳青霉烯类抗生素的耐药机制 被引量：34

Mechanism of carbapenem resistance in Acinetobacter baumannii
在线阅读 下载PDF
导出
摘要 鲍曼不动杆菌（Acinetobacter baumannii）是医院感染的重要条件致病菌。鲍曼不动杆菌感染常发生在具有基础疾病的患者,如皮肤黏膜或呼吸道保护屏障受损的重症患者,正在接受侵袭性诊疗措施以及使用免疫抑制剂和广谱抗生素的患者。鲍曼不动杆菌常引起呼吸机相关肺炎、尿路感染、菌血症、皮肤软组织感染、腹腔和中枢神经系统感染,鲍曼不动杆菌也是战争相关伤口主要病原体之一。
作者 周娇娇 朱惠莉
机构地区 复旦大学附属华东医院呼吸科
出处 《中国感染与化疗杂志》 CAS 北大核心 2014年第5期446-450,共5页 Chinese Journal of Infection and Chemotherapy
关键词 鲍曼不动杆菌 碳青霉烯类抗生素 耐药机制
分类号 R446.5 [医药卫生—诊断学]
  • 相关文献

参考文献37

  • 1u. S. Department of Health and Human Services. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States 2013[EB/OL]. http://www. cdc. gov/ drugresistance/ threat-report- 2013/ pdf! ar-threats-2013-508. pdf. (Accessed 23April 2(13). [Epub ahead of print].
  • 2Bonnin RA. Nordmann P. Potron A. et aL Carbapenern-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii [J]. Antimicrob Agents Chernother , 2011.55(1):349-354.
  • 3Robledo IE. Aquino EE. Sante MI. et al, Detection of KPC in Acinetobacter spp. in Puerto Rico[]]. Antimicrob Agents Chernother , 2010.54(3): 1354-1357.
  • 4Karthikeyan K. Thirunarayan MA. Krishnan P. Coexistence of blaOXA-23 with blaNDM-l and armA in clinical isolates of Acinetobacter baumannii from India [J]. J Antimicrob Che- mother. 2010,65(10) :2253-2254.
  • 5Kaase M. Nordmann p, Wichelhaus T A. et al. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt [J]. J Antimicrob Chemot her , 2011.66(6): 1260-1262.
  • 6Espinal P. Macia MD. Roca r. et aL First report of an OXA- 23 carbapenernaseproducing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain [J]. Antimicrob Agents Chemother . 2013.57(1) :589591.
  • 7Lee MH, Chen TL. Lee YT. et al. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan[J]. J Microbiol Immunol Infect. 2()13.46(6) :419-424.
  • 8Wang X. Zong Z. Lu X. Tn2008 is a major vehicle carrying bla (OX A-23) in Acinetohacter baumannii from China[J]. Diagn Microbial Infect Dis. 2011.69(2) :218-222.
  • 9Ku WW. KungCH. LeeCH, etaL Evolution of carbapenem resistance in Acinetobacter baumannii , An 18-year longitudinal study from a medical center in northern Taiwan[J]. J Microbiol Immunol Infect. 2013, pii , s1684-1182(13)OOI21-7. [Epub ahead of print]'.
  • 10Afzal-Shah M. Woodford N. Livermore DM. Characterization of OXA-25. OXA-26, and OXA-27. molecular class D beta-Iactarnases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J]. Antimicrob Agents Chemot her , 2001.45 (2) : 583-588.

二级参考文献12

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量：137
  • 2Clinical and Laboratory Standards Institute(CLSI). Perform- ance standards for Antimicrobial susceptibility testing [S]. M100-22, 2012.
  • 3Towner KJ. Acinetobacter: an old friend, but a new enemy[J]. J HospInfect, 2009, 73(4) :355-363.
  • 4Bergogne-Brzin E. Resistance of Acinetobacter spp. to anti- microbials-overview of clinical resistance patterns and hera- peutic problems. Acinetobacter, microbiology, epidemiology, infections, management[M]. Boca Raton : CRC Press, 1996 133-183.
  • 5Peleg AY, Seifert H, Paterson DL. Acinetobacter bauman- nii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3) :538-582.
  • 6Karageorgopoulos DE, Kelesidis T, Kelesidis I, et al. Tigecy- cline for the treatment of multidrug-resistant (includlng car-bapenem-resistant) Acinetobacter infections: a review of the scientific evidence[J]. J Antimicrob Chemother, 2008, 62 (1) : 45-55.
  • 7Anthony KB, Fishman NO, Linkin DR, et al. Clinical and microbiological outcomes of serious infections with multidrug- resistant Gram-negative organisms treated with tigecycline [J]. Clin Infect Dis, 2008, 46(4): 567-570.
  • 8Schafer JJ, Goff DA, Stevenson KB, et al. Early experience with tigecycline for ventilator-associated pneumonia and bac teremia caused by multidrug-resistant Acinetobacter bauman- nil [J]. Pharmacotherapy, 2007, 27(7): 980-987.
  • 9Reid GE, Grim SA, Aldeza CA, et al. Rapid development of Acinetobacter baumannii resistance to tigecycline[J]. Phar- macotherapy, 2007, 27(8): 1198-1201.
  • 10Peleg AY, Adams J, Paterson DL. Tigeeycline efflux as a mechanism for nonsusceptibility in Acinetobacter baurnannii [J]. Antimicrob Agents Chemother, 2007, 51 (6): 2065- 2069.

共引文献93

同被引文献356

引证文献34

二级引证文献155

中国感染与化疗杂志
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部